Main Industry
Health Care
Main Product/Service
Postoperative Liver Cancer Diagnostic Service Platform
The content above was translated by Ai
Founded Year
2014
Unified Business No.
24666342
Status
Active
Number of Employees
6
Total Paid-in
Capital
15,000,000 (NT$)
Location of Company
Taiwan
, Kaohsiung City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Since 2012, in response to the clinical importance of in vitro diagnostics (IVD) for prevention, treatment, and prognosis, our company's R&D team has integrated interdisciplinary biomedicine with microelectronics to develop a light-induced dielectrophoresis platform (referred to as LIDEP). Among current IVD cancer detection products, the requirements for accuracy, sensitivity, and efficiency are becoming increasingly high; however, existing IVD products for cancer detection are all based on immunochemical methods, which are not rapid tests and are highly expensive. Therefore, the cancer screening (detection) industry still possesses room for advancement. The LIDEP platform developed by our company is moving forward precisely toward these goals of improvement.
The content above was translated by Ai
